It is assumed that these variant haemoglobins are benign with less clinical significance, but they may be implicated for haemolysis, polycythaemia and impaired oxygen affinity. Unfortunately, data available for these variant haemoglobins is limited.
In our case, we were unable to detect the cause for low SpO 2 with a normal PaO 2 in an apparently normal patient. Further molecular or genetic studies were required, but it would have added financial, psychological burden and deviated her from the actual treatment she sought. Presence of normal PaO 2 does not necessarily indicate that nothing is wrong, as in cases of methaemoglobinemia and carboxyhaemoglobinemia; these variant haemoglobins provide diagnosis of exclusion in absence of signs and symptoms of hypoxaemia, presence of normal cardiovascular testing and absence of commonly known haemoglobinopathies. We think that not all cases of low SpO 2 with normal PaO 2 should be considered abnormal and these variant haemoglobins should be considered in differential diagnosis while investigating an asymptomatic patient with unexpectedly low SpO 2 .
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Gum elastic bougie as a tube exchanger: Modified technique
Sir,
The standard gum elastic bougie (GEB) which is used mainly for aiding in difficult laryngoscopy and intubation can be used as a tube exchanger also. The essential steps of tube exchange using GEB require it to be inserted into the lumen of the endotracheal tube (ETT) until the markings of the GEB correlate with the markings on the ETT. This indicates that the tip of the GEB is at the tip of the ETT. [1] Subsequently, cuff of the ETT is deflated and the ETT withdrawn gently over the GEB, whereas the operator end of the GEB is held securely. However, by the time, the tip of the ETT comes to lie in the oral cavity; the whole length of the GEB gets lost within the ETT lumen and the oral cavity resulting in the anaesthesiologist losing control over the GEB completely. This is because the GEB measures 60 cm in length and an ETT of 8.0 mm inner diameter (ID) measures 36 cm [from its distal end to the edge of the blue connector, Figure 1a ], thus resulting in only 24 cm of GEB length remaining outside the ETT. Furthermore, the ETT is usually fixed around 22-23 cm at the angle of the mouth. Hence, overall 59-60 cm length of the GEB is required to be inserted into the ETT (36 cm ETT length and 22-23 cm length inside the oral cavity) before the shaft of the GEB could be recovered outside the oral cavity, when the ETT tip comes out. Therefore, invariably the anaesthesiologist ends up losing control over the GEB for a brief while. This total loss of control over the GEB can result in the GEB either migrating deeper into the trachea, thus stimulating the carina in an already/almost awake patient, or there is a risk that the GEB comes out of the larynx along with the ETT and gets accidentally placed in the oral cavity or oesophagus. The traditional airway exchange catheters measure more than 80 cm (83 cm, 11 and 14 G), and, therefore, do not have this problem. [2] As long as the length of the GEB is more than twice that of the ETT, this problem should not happen. Bougies from other manufacturers that measure approximately 70 cm in length are available, and these problems are unlikely to be encountered with these. [3] Having experienced these problems with the traditional GEB when used as tube exchanger on a couple of occasions, we have devised two unique solutions to overcome these problems.
First, prior to planned extubation of the ETT, the ETT is cut at its 24-26 cm mark (1 or 2 cm above the oral cavity), and the blue connector is fixed [ Figure 1a ]. Since the ETT length now is reduced by almost 10 cm relative to ETT, it ensures that the length of GEB (60 cm) is now more than double that of the ETT (26 × 2 = 52 cm). Hence, nearly 34-36 cm of it lies outside the ETT when correctly positioned and therefore, it allows the anaesthesiologist to be always in control of the GEB during the procedure of extubation. However, it requires that another ETT be cut to similar length and kept beside the patient for future tube exchange if need be. The second solution involves attaching an uncuffed 4.5 mm ID ETT to the proximal end of the bougie. This snugly fits the GEB [ Figure 1b ] and requires considerable force to separate the two. Thus, this setup helps in lengthening the GEB to >80 cm.
We are confident these solutions to GEB can help minimise the complications discussed earlier. While a GEB may not be suitable for tube exchange through the nasal route due to the limitation of length, these 2 modifications can enable the traditional GEB to be used through both oral and nasal routes. Though an airway exchange catheter is ideal for extubation of the difficult airway and tube exchange, the modified GEB with the second solution that we have provided appears to have an edge as it is useful in aiding difficult intubation also.
Insulin IP Calc: A smartphone application for insulin infusion protocol in Intensive Care Units
Sir, Insulin infusion for hyperglycaemia management in the Intensive Care Unit (ICU) is often based on paper-based, complex protocols that are variable rate insulin infusion protocols or sliding scale regimens. The older sliding scale regimens are considered obsolete in current practice, while more complex, validated variable rate algorithms such as the Yale insulin infusion protocol, Portland protocol and University of Washington protocol are increasingly being used in ICUs.
The conversion of paper-based protocols to computer-based software protocols may improve adherence and reduce errors in implementation. [1] Goldberg et al. described the 'Yale Insulin infusion protocol' an intuitive, structured variable rate insulin infusion protocol for hyperglycaemia management in ICU. [2] The protocol is not tailored for use in diabetic ketoacidosis or hyperglycaemic hyperosmolar states. Numerous subsequent studies have validated this protocol in cardiac surgical and medical ICUs. [3] Older guidelines for hyperglycaemia management emphasised, 'Tight Control' insulin infusion regimens that kept blood glucose in the target range of 80-110 mg/dL. Later studies showed an increased risk of major hypoglycaemic events with these lower targets. [4] In view of this, the revised consensus guidelines of the American Association of Clinical Endocrinology and American Diabetes Association recommended a blood glucose target of 140-180 mg/dL. [4] Accordingly, the Yale insulin infusion protocol was modified and updated to a blood glucose target of 120-160 mg/dL by Shetty et al., with a median target of 150 mg/dL. [5] We describe, 'Insulin IP Calc', a simple, point of care, Android operating system smartphone application created by us, based on the updated Yale insulin infusion protocol that can be used as a bedside clinical decision support app for insulin infusion management. It can be freely downloaded and installed from its project page https://sourceforge. net/projects/insulinipcalc in an Android-based smartphone or tablet for use at the bedside. The use of software-based variable rate insulin infusion protocols can potentially simplify the implementation of the Yale algorithm by critical care providers. It may also reduce human errors and the incidence of complications such as severe hypoglycaemia, thus decrease the risk of morbidity and mortality. The application, when launched, requires input of an initial blood glucose value in mg/dL, measured by point of care glucometer devices [ Figure 1 ]. The user then calculates the initial insulin infusion rate, which as per algorithm recommends an initial bolus before the infusion. Subsequent values to input include the current (new) blood glucose value (measured at hourly intervals as per protocol, until the values stabilise), the previous blood glucose value and the previous insulin infusion rate. The application then calculates and recommends an action based on the Yale algorithm.
